Published in Gene Therapy Weekly, January 5th, 2006
"To evaluate the feasibility and safety of adenovirus-mediated gene therapy as a treatment for tumor seeds in the vitreous of children with retinoblastoma," wrote P. Chevez-Barrios and colleagues, Baylor College of Medicine, "an Institutional Biosafety Committee-, Institutional Review Board; Recombinant DNA Advisory Committee-, and U.S. Food and Drug Administration-approved phase I study used intrapatient dose escalation of adenoviral vector containing a herpes simplex...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.